ANI Pharmaceuticals, ILUVIEN, fluocinolone acetonide intravitreal implant, SYNCHRONICITY, Phase 4 clinical trial, chronic non-infectious uveitis, NIU-PS, ophthalmology,

PRINCETON, N.J. — October 12, 2026 ANI Pharmaceuticals, Inc. announced positive six-month and 24-month results from SYNCHRONICITY, its Phase...